Work

Two Blastic Plasmacytoid Dendritic Cell Neoplasms treated with the CD123‐targeted agent Tagraxofusp presenting divergent outcomes

Year: 2026
Type: article
Abstract: Dear Editors
Language: English
Subfield: Physiology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,480
OpenAlex ID: W7212632750
FWCI:
Cites: 9
Cited by:
Related to: